Individual Shareholder Nam Expands Injunction Scope Against Enzychem Lifesciences Temporary Meeting; Management Dispute Intensifies
The applicant Nam filed an amended petition on July 9, 2026, expanding the scope of the injunction application to prohibit the temporary shareholders' meeting of Enzychem Lifesciences.
The amended request includes additional agenda items concerning executive officer and representative executive officer related articles of incorporation, intensifying the management dispute.
The company stated it will respond in accordance with legal procedures, and the schedule for the temporary shareholders' meeting on July 23, 2026, remains unchanged.
[AI Summary]This expansion of the injunction application elevates the management dispute to a heightened legal battle, increasing corporate governance uncertainty. Short-term stock price volatility and operational disruption are expected, and investors should closely monitor court decisions and meeting outcomes.
KOSDAQ Filing Information
[Correction of Description] Filing/Application of Lawsuit, etc. (Management Dispute Lawsuit) (Provisional Injunction Prohibiting Holding of Extraordinary General Meeting of Shareholders)